Recent Research Information on Aplastic Anemia, MDS, and PNH

AA&MDSIF strives to keep patients, families, and hematology/oncology professionals up-to-date with developments in research and practice relevant to aplastic anemia, MDS and PNH. Shown below are recent articles from major hematology/oncology journals, retrieved from the National Library of Medicine’s PubMed portal to their MEDLINE database of journal citations and abstracts of the biomedical literature from around the world.


Looking for research oriented for patients and caregivers? For select reviews of important medical journal articles, written by hematology/oncology professionals, visit Research Reviews for Patients. These reviews interpret the most relevant information for patients from the latest published research.

You can also read Research Summaries for Patients that are lay language explanations of scientific meetings and symposia.

Summary information is listed by publication date, title, journal title and senior author. By default, the articles are listed by their publication date in reverse chronological order, from the most recent article to oldest article. Clicking the date column heading will sort them the other way, from oldest to newest.

"Publication date" in most cases means when the article first appeared in the electronic/online issue of a journal, in advance of when it appears in the print journal. Keep in mind some articles may appear online months before appearing in print, and that some may be from online-only journals.

You can also alphabetically and reverse alphabetically sort articles, primary authors and journal titles by clicking their column heading. To find articles by disease type, choose it from the drop-down menu named "Filter by Disease", and only articles about those diseases will appear. The search box labeled “Filter by Search Term” lets you search for a word in the article title, author, or journal name.

When you open an article citation by clicking on the title, article summary information (this time including all authors) is again shown, and in most cases you can view the article abstract. In some cases the abstract is unavailable, and not shown. You can also progress to the article’s PubMed entry by clicking the PubMed ID number link, shown directly under the title. Here you can purchase the article for download viewing or view through your institutional library’s access. In some cases, full text viewing is free either from the publisher’s site or from PubMed Central, an searchable aggregation site of free full text articles.

The PubMed Web site has extensive features, along with help tools and links to other databases. Regular users are encouraged to become familiar with its many capabilities.

Publication Date Article Title Journal Title Primary Author Bone Marrow Disease(s)
05/01/2014 Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide Ann Hematol Gaballa MR myelodysplastic syndromes (MDS)
04/11/2014 Bone marrow mesenchymal stem cells from aplastic anemia patients preserve functional and immune properties and do not contribute to the pathogenesis of the disease Haematologica Bueno C aplastic anemia
04/10/2014 Blood stream infection after stem cell transplantation in children with idiopathic aplastic anemia Biol Blood Marrow Transplant Kobayashi R aplastic anemia
04/10/2014 SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution Am J Hematol Lin CC myelodysplastic syndromes (MDS)
04/10/2014 Myelodysplastic syndromes in the United States: an update for clinicians Ann Med. Troy JD myelodysplastic syndromes (MDS)
04/10/2014 Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion Br J Haematol Sánchez-García J myelodysplastic syndromes (MDS)
04/09/2014 Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes Br J Haematol Zeidan AM myelodysplastic syndromes (MDS)
04/08/2014 Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function Ann Hematol Castelli R myelodysplastic syndromes (MDS)
04/01/2014 Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next? Haematologica Samarasinghe S aplastic anemia
03/28/2014 p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q) Haematologica Saft L myelodysplastic syndromes (MDS)